Life sciences

#AI tools #Lab Thread #Laboratory data #Life sciences

Lab Thread launches new AI tools and strengthens platform

Lab Thread, a UK-based life science software company, has launched a new Model Context Protocol (MCP) server that lets scientists connect their own AI assistants directly to their laboratory data. The launch coincides with Lab Thread’s formal incorporation in the United States, and opening of a Boston office, enabling US-based… Read More

#News

UK Budget
#Association of the British Pharmaceutical Industry #Investment #Life sciences #UK #UK budget

UK Budget promises £70m for life sciences and lifts VAT on free medicines

In the 2026 Budget, Chancellor John Healey moved to settle a long-running VAT issue that had become a barrier to pharmaceutical companies providing free-of-charge medicines to NHS patients. Medicines supplied free of charge can provide a vital route to treatment for patients with serious conditions. Read More

#Business & Investment #News #Trending News

#Awards #Biopharma #Biotech #BioUK #Life sciences

BioUK Awards 2026 celebrate innovation in UK life sciences

BioUK has announced the winners of the 18th annual BioUK Awards following a ceremony hosted at the Royal Lancaster Hotel, London.   The biopharma and biotech winners of the 2026 BioUK Awards included:  The Best Start-Up Biotech Company Award, sponsored by Milton Park, was awarded to… Read More

#News

Basel map
#Academic #Biotech #Drug development #Drug discovery #Life sciences

How the right environment accelerates biotech innovation

Christof Klöpper, CEO of Basel Area Business and Innovation, discusses how ecoystems for biotech can advance innovation and how the Basel area is an example of an impressive concentration of talent.  A decade ago, the typical formula for biotech locations went something like this: emerge from an academic institution or… Read More

#Exclusive Content

#Cancer research #Life sciences #London Cancer Hub #Populate #Science and innovation

Populate appoints Director of Science and Innovation 

Populate, a management platform owned by mixed-use developer Socius, has appointed Dr Angela Kukula as Director of Science and Innovation.  Dr Kukula was previously Chief Executive of MedCity and Director of Life Sciences at London & Partners, where she championed London’s life sciences sector on the global… Read More

#Cancer Research #News

Gen Z
#ABPI #Association of the British Pharmaceutical Industry #Career #Life sciences

ABPI creates new Youth Advisory Council to engage Gen Z

The Association of the British Pharmaceutical Industry (ABPI) has launched its first Youth Advisory Council, a new advisory body made up of young people aged 16 to 19 from across the UK, tasked with challenging and shaping how the pharmaceutical industry inspires, engages and communicates with the next generation. Read More

#News

#Events #JP Morgan Healthcare Week 2027 #Life sciences

Cambridge and London Life Sciences Showcase returns in 2027 

o2h co-discovery has announced that the Cambridge and London Life Sciences Showcase will return for its second edition during JP Morgan Healthcare Week 2027 in San Francisco.   The event provides emerging companies with an international platform to present their science, innovation and growth opportunities directly to investors,… Read More

#News

#CN Bio #Drug discovery #Events #Life sciences #Organ-on-a-chip #R&D

Speaker line-up and scientific programme for organ-on-a-chip e-symposium 

The full scientific programme for the 2026 ‘From Insight to Decision’ e-symposium, which is taking place on 2 and 8 December, has been announced by CN Bio. The event will feature expert-led sessions offering practical, real-world guidance on organ-on-a-chip (OOC) use within existing R&D strategies.  Launched in… Read More

#News

#Leadership appointment #Life sciences #Microfluidics #Nuclera

Nuclera appoints Carl Raimond as Chief Executive Officer 

Nuclera has appointed Carl Raimond as Chief Executive Officer, effective immediately. Dr Michael Chen, Nuclera’s Co-founder and former CEO, transitions to the role of Chief Scientific and Business Officer, continuing to provide scientific leadership while supporting market development and strategic partnerships.  The leadership transition reportedly marks the… Read More

#News

Human cells
#Cell analysis #Cytomos #Leadership appointment #Life sciences

Cytomos appoints board member to support commercialisation drive

Edinburgh-based biotechnology company Cytomos has appointed senior life sciences executive Dr Alex Jones as non-executive director, as it looks to accelerate the commercialisation of its cell analysis technology. Dr Jones brings extensive expertise in life science tools and cell and gene therapy. As the incumbent CEO of Cellply, and previously… Read More

#News

#Investment #Life sciences

UK could gain £1.9bn in growth through university investment  

Almost £2 billion (£1.9bn) of economic value could be generated over the next decade if investment rises in laboratories, research facilities, science parks and innovation districts, a new report from Lloyds suggests.   The report, Innovation Foundations, states that underinvestment in university estates is limiting private sector R&D, spinout creation and local economic growth. It states that the UK… Read More

#News

#Investment #Life sciences #Venture funds

Sofinnova Partners expands expertise with new partner  

Venture capital firm Sofinnova Partners has appointed a deep pharma and drug development expert as Partner, the company has announced.  David Evans is a physician-scientist with deep pharma and drug development expertise. He joins from the Roche Venture Fund, where he previously served as Senior Investment Director. There, he built a… Read More

#News

#Clinical trials #Drug discovery #Life sciences

Why science parks will shape the next decade of scientific discovery 

By Angie Reynolds, Chief Operating Officer at University of Birmingham Enterprise and Board Director at the UK Science Park Association (UKSPA).  Birmingham Research Park is celebrating its 40th anniversary this year. Any milestone creates an opportunity to take stock about where you’ve come from and where you’re going – which seems timely given ongoing debates about… Read More

#Exclusive Content

Delegates at a conference
#Life sciences #SLAS

SLAS2027 Innovation AveNEW entries open for submissions 

SLAS has announced that applications for SLAS2027 Innovation AveNEW programme are now open.  Part of the SLAS Ignite Program for start-up companies in the life sciences discovery and technology sectors, the competition is now accepting entries until Monday 14 September.  Innovation AveNEW companies who opt-in… Read More

#News

#AstraZeneca #Drug discovery #Life sciences #o2h #o2h Discovery #o2h Group #o2h Ventures

CWOW and the future of integrated drug discovery

Held from 11–19 June 2026, CWOW welcomed more than 5,000 attendees across 37 venues, delivering over 280 sessions and bringing together investors, entrepreneurs, academics, policymakers, operators, local communities and the wider biotech and techbio community from across the UK and beyond. Read more about the event here. Below, DDW… Read More

#Exclusive Content